Relief as 280 jobs saved at Dublin Pfizer plant
Up to 280 jobs have been saved at the Pfizer manufacturing facility in Dun Laoghaire, Co Dublin, after it was purchased by the world's largest biotechnology company Amgen.
The deal, which is expected to be finalised by the summer, will result in 240 workers being transferred to Amgen and 40 remaining with Pfizer.
Madhu Balachandran, senior vice president at Amgen Manufacturing, revealed that as the firm expands internationally, the Dublin site will help deliver a growing supply of its medicines for patients worldwide.
"We are impressed with the technical expertise and commitment to excellence demonstrated by the employees who work at the Dun Laoghaire site and look forward to welcoming them to Amgen's global manufacturing team," he added.
"We are grateful to the Irish government and IDA Ireland for their support in helping us secure this world-class facility and look forward to a strong, productive relationship in the years ahead."
Amgen manufactures and delivers human therapeutics which have changed the practice of medicine and helped millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses.
Local TD, Tanaiste Eamon Gilmore, said the retention of the jobs and the prospect of further growth by Amgen ends a period of uncertainty for management and staff.
"It is particularly gratifying to welcome a company of the calibre of Amgen to Dun Laoghaire in this, the new Government's first week in office," said Mr Gilmore.
"This announcement is proof that Ireland continues to be a highly attractive location for foreign direct investment."